Dexmedetomidine vs Midazolam in Coronary Artery By-pass Surgery
A Comparative Evaluation of Dexmedetomidine and Midazolam ınfusions With Respect to Postoperative Delirium in Patients Undergoing Coronary Artery Bypass Grafting
Cumhuriyet University
60 participants
Jan 15, 2026
INTERVENTIONAL
Conditions
Summary
The aim is to compare the incidence of postoperative delirium following coronary artery bypass grafting (CABG) between patients receiving dexmedetomidine and those receiving midazolam infusions.
Eligibility
Inclusion Criteria1
- Adult patients scheduled for elective coronary artery bypass graft surgery.
Exclusion Criteria5
- Patients with renal disorders,
- Patients with hepatic disorders,
- Patients with neuropsychiatric disorders,
- Patients whom informed consent could not be obtained
- Patients who declined to participate in the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Following the induction of standard general anaesthesia, dexmedetomidine will be administered as a continuous intravenous infusion at a dose of 0.3-0.7 µg/kg/h.
Following the induction of standard general anaesthesia, midazolam will be administered as a continuous intravenous infusion at a dose of 0.03-0.06 mg/kg/h.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07411794